Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands - Balakumar Vijayakrishnan

Name: Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands - Balakumar Vijayakrishnan
Start: 2026-10-14T14:40
End: 2026-10-14T15:10
Location: ExCeL London

ELRIG Drug Discovery 2026 · 14 October 2026 · 14:40–15:10 · Auditorium 3

Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands - Balakumar Vijayakrishnan was a session at ELRIG Drug Discovery 2026 on 14 October 2026 in London, with 1 speaker on record.

Speakers

Balakumar Vijayakrishnan — Speaker Director Of Bioconjugation and Analytical, Astrazeneca